Used in pharmaceutical research as a key intermediate in the synthesis of selective serotonin reuptake inhibitors (SSRIs). It exhibits potential in the development of central nervous system (CNS) active agents due to its structural affinity for neurotransmitter receptors. Its scaffold supports optimization for improved bioavailability and receptor binding, making it valuable in creating novel antidepressants and anxiolytics. Also explored in the design of kinase inhibitors for oncology applications, where it contributes to blocking signal transduction pathways in cancer cells.